Recently, primary ovarian cancer cells’ DSG2 immunohistochemistry signals and mRNA levels suggested DSG2 as a prognostic and diagnostic biomarker for ovarian cancer [14]. This evidence concerns the gene DSG2 and ovarian carcinoma.